WallStreetZenWallStreetZen

NASDAQ: BLAC
Bellevue Life Sciences Acquisition Corp Stock Ownership - Who owns Bellevue Life Sciences Acquisition?

Insider buying vs selling

Have Bellevue Life Sciences Acquisition Corp insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BLAC insiders and whales buy or sell their stock.

BLAC Shareholders

What type of owners hold Bellevue Life Sciences Acquisition Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Kuk Hyoun Hwang35.58%2,000,500$21.38MInsider
Bellevue Global Life Science Investors LLC35.58%2,000,500$21.38MInsider
Polar Asset Management Partners Inc4.62%260,000$2.78MInstitution
Saba Capital Management LP4.45%250,000$2.67MInstitution
Aqr Arbitrage LLC4.45%249,995$2.67MInstitution
Rivernorth Capital Management LLC4.36%245,115$2.62MInstitution
Schechter Investment Advisors LLC3.76%211,227$2.26MInstitution
Exos Tfp Holdings LLC3.56%200,000$2.14MInstitution
Wolverine Asset Management LLC3.26%183,110$1.96MInstitution
Kim LLC3.25%182,693$1.95MInstitution

1 of 3

BLAC vs Shell Company Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BLAC41.88%58.12%
BNIX51.33%8.69%
GMFI45.67%36.21%Net SellingNet Selling
HAIA5.27%94.73%
IGTA47.30%26.28%

Bellevue Life Sciences Acquisition Stock Ownership FAQ

Who owns Bellevue Life Sciences Acquisition?

Bellevue Life Sciences Acquisition (NASDAQ: BLAC) is owned by 52.82% institutional shareholders, 73.29% Bellevue Life Sciences Acquisition insiders, and 0.00% retail investors. Kuk Hyoun Hwang is the largest individual Bellevue Life Sciences Acquisition shareholder, owning 2.00M shares representing 35.58% of the company. Kuk Hyoun Hwang's Bellevue Life Sciences Acquisition shares are currently valued at $21.43M.

If you're new to stock investing, here's how to buy Bellevue Life Sciences Acquisition stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.